NCT02320435 2026-02-12A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical TrialHoffmann-La RochePhase 3 Active not recruiting154 enrolled